Multi-component nurse delivered intervention for major depressive disorder in patients with cancer
- Conditions
- Cancer and depressionMental and Behavioural DisordersReaction to severe stress and adjustment disorders
- Registration Number
- ISRCTN84767225
- Lead Sponsor
- niversity of Edinburgh (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 200
Patients attending Edinburgh Cancer Centre identified through a screening process or by referral and noted to have:
1. Definite or probable major depressive disorder on Structured Clinical Interview for Depression (SCID) interview
2. SCL-20 depression score of at least 1.72
3. A diagnosis of cancer
Predicted survival less than 6 months; another complicating and uncontrolled medical problem or where antidepressants are contraindicated; too ill to participate in treatment due to ongoing cancer therapy; complicating major psychiatric diagnosis or an alcohol or substance misuse problem; chronic depression; under active treatment for their depression; judged to be in need of urgent psychiatric treatment; unable to communicate adequately due to language problems or cognitive impairment; unable to travel to centre for treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The principal outcome measure will be a 50% reduction in the SCL-20 depressive symptoms score from baseline.
- Secondary Outcome Measures
Name Time Method Secondary measures will be:<br>1. Mean depression scores from the SCL-20<br>2. Remission specified as an SCL-20 score of <0.75<br>3. The presence of major depressive disorder assessed by SCID diagnostic interview<br><br>Subsidiary outcome measures will be:<br>1. Quality of life measured on the World Health Organisation (WHO) EQ-5D<br>2. EORTC-QLQ-C30<br>3. Anxiety measured on the 10 anxiety items of the SCL-90<br>4. A measure of self-efficacy, coping and social support<br>5. An estimate of the direct health care costs measured by case note review and patient questionnaire<br><br>The outcomes will be measured at 3, 6 and 12 months